Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Genzyme
plans to boost drug's production 4:33 AM 12/4/2009
Boston Globe
Genzyme Corp has scrapped its application to produce Lumizyme to treat the rare
genetic disorder Pompe disease in midsize bioreactors.
...
Chickenpox
vaccine may protect kids from shingles 3:12 AM 12/4/2009
Reuters
A study of more than 170,000 children 12 and under receiving Merck & Co's chickenpox
vaccine found fewer cases of shingles (herpes zoster), a painful recurrence of the chickenpox virus.
...
Biogen ups offer
for Facet Biotech 5:08 PM 12/3/2009
Reuters
Biogen Idec Inc raised its offer to buy Facet Biotech Corp. Biogen and Facet are
jointly developing daclizumab to treat multiple sclerosis and volociximab for solid tumors.
...
ZymoGenetics cuts
jobs, stops immunology research 4:28 PM 12/3/2009
Reuters
ZymoGenetics Inc will cut its workforce by about 15 percent and discontinue immunology
discovery research programs to focus efforts on the market for synthetic blood-clotting enzyme Recothrom.
...
US
FDA staff note safety issues with Novartis drug 12:11 PM 12/3/2009
Reuters
US FDA reviewers have found Novartis drug everolimus effective for
preventing rejection of transplanted kidneys but raised safety issues ahead of an advisory panel review.
...
US FDA: Glaxo warns of
heart risk from HIV drug 11:12 AM 12/3/2009
Reuters
GlaxoSmithKline warned of a possible link between its HIV drug Lexiva (fosamprenavir)
and heart attacks in HIV-infected adults.
...
Measles
Deaths Drop 78% in 8 Years Under Global Vaccine
Effort 11:41 AM 12/3/2009
Bloomberg
A
global measles vaccination campaign inoculated 700 million children and saved 4.3 million lives. Measles is a
contagious respiratory illness spread through coughing and sneezing and is the world’s leading cause of death
in children.
...
US
group asks FDA to ban Abbott diet drug 9:08 AM 12/3/2009
Reuters
Public Citizen cites the Scout study on Abbott Laboratories Inc's weight-loss drug
Meridia (sibutramine) and heart problems.
...
France's
BioMerieux sells ExonHit stake 6:47 AM 12/3/2009
Forbes
BioMerieux sold its roughly 5 percent stake in biotechnology company ExonHit
Therapeutics.
...
Astra to pay up to
$1.24 bln for Targacept drug 5:07 AM 12/3/2009
Reuters
AstraZeneca bought rights to an experimental antidepressant from Targacept in a deal
worth up to $1.24 billion to boost its pipeline.
...
Novartis wins EU approval for lung drug 3:38 AM 12/3/2009
Reuters
Novartis won Europan Union approval for use of its Onbrez Breezhaler
(indacaterol maleate; QAB149) to widen the bronchial passages of patients with chronic obstructive pulmonary
disease (COPD).
...
Dyax
shares soar after FDA approves genetic-disorder drug 10:10 AM 12/2/2009
Forbes
The US FDA has approved ecallantide for the treatment of acute
attacks of hereditary angioedema (HAE) in patients 16 years of age and older.
...
CytRx says FDA lifts
clinical hold on Lou Gehrig's
drug 9:28 AM 12/2/2009
Reuters
CytRx Corp
said the US FDA has lifted a clinical hold on its experimental oral drug arimoclomol for the treatment of Lou
Gehrig's disease after accepting the company's revised trial protocol.
...
FDA
Fast Tracks Keryx Immune-System Cancer Drug 9:11 AM 12/2/2009
Wall Street
Journal
Keryx Biopharmaceuticals Inc's experimental drug to treat a kind of cancer in white blood
cells received fast-track status from the US FDA.
...
<- Day Earlier | Today's News
|
